These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8533725)

  • 21. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1991 Jun; 265(22):2934. PubMed ID: 1903461
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
    Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ
    J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528
    [No Abstract]   [Full Text] [Related]  

  • 23. Uncertain miracle: a biotech drug extends a life, but at what price? For Ms. Lees, treatment bill now totals $7 million; her bones keep crumbling; guilt of another $1,400 day.
    Wall St J (East Ed); 2005 Nov; ():A1, A15. PubMed ID: 16502532
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.
    Narta UK; Kanwar SS; Azmi W
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):208-21. PubMed ID: 17011787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early access experience with VPRIV(®): recommendations for 'core data' collection.
    Hughes DA; Al-Sayed M; Belmatoug N; Bodamer O; Böttcher T; Cappellini M; Cohen IJ; Eagleton T; Elstein D; Giraldo P; Jones S; Kaplinsky C; Lund A; Machaczka M; Mengel E; Pastores GM; Rosenbaum H; Sjo M; Tiling N; Tsaftaridis P; Zimran A; Weinreb N
    Blood Cells Mol Dis; 2011 Aug; 47(2):140-2. PubMed ID: 21146428
    [No Abstract]   [Full Text] [Related]  

  • 26. Miglustat. Oxford GlycoSciences/Actelion.
    Lachmann RH
    Curr Opin Investig Drugs; 2003 Apr; 4(4):472-9. PubMed ID: 12808890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.
    Holubar J; Bres V; Costes-Martineau V; Pers YM
    Blood Cells Mol Dis; 2018 Feb; 68():112-114. PubMed ID: 28559130
    [No Abstract]   [Full Text] [Related]  

  • 28. Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
    Ben Turkia H; Gonzalez DE; Barton NW; Zimran A; Kabra M; Lukina EA; Giraldo P; Kisinovsky I; Bavdekar A; Ben Dridi MF; Gupta N; Kishnani PS; Sureshkumar EK; Wang N; Crombez E; Bhirangi K; Mehta A
    Am J Hematol; 2013 Mar; 88(3):179-84. PubMed ID: 23400823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of adult Gaucher disease.
    Schmitz J; Poll LW; vom Dahl S
    Haematologica; 2007 Feb; 92(2):148-52. PubMed ID: 17296562
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for the restart of imiglucerase in patients with Gaucher disease: recommendations from the European Working Group on Gaucher disease.
    Hollak CE; Aerts JM; Belmatoug N; Bembi B; Bodamer O; Cappellini D; Collin-Histed T; Cox TM; Deegan P; Giraldo P; Hughes D; Lukina E; Manuel J; Michelakakis H; Di Rocco M; Vellodi A; Zimran A
    Blood Cells Mol Dis; 2010; 44(2):86-7. PubMed ID: 20022271
    [No Abstract]   [Full Text] [Related]  

  • 31. Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
    Gonzalez DE; Turkia HB; Lukina EA; Kisinovsky I; Dridi MF; Elstein D; Zahrieh D; Crombez E; Bhirangi K; Barton NW; Zimran A
    Am J Hematol; 2013 Mar; 88(3):166-71. PubMed ID: 23386328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher.
    Belmatoug N; Launay O; Carbon C
    Lancet; 1998 Jul; 352(9123):240. PubMed ID: 9683246
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease.
    den Bakker MA; Grünberg K; Boonstra A; van Hal PT; Hollak CE
    Histopathology; 2012 Aug; 61(2):324-6. PubMed ID: 22690977
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease.
    Serratrice C; Bengherbia M; Alessandrini M; Grosbois B; Camou F; Pers YM; Bismuth M; Marie I; Belmatoug N; Berger M;
    Blood Cells Mol Dis; 2014; 53(1-2):94-6. PubMed ID: 24411065
    [No Abstract]   [Full Text] [Related]  

  • 36. Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program.
    Goldwater RS
    J Intraven Nurs; 1996; 19(2):83-8. PubMed ID: 8852168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of treating Gaucher disease.
    Beutler E
    Nat Med; 1996 May; 2(5):523-4. PubMed ID: 8616707
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme replacement therapy in type III Gaucher disease.
    Tylki-Szymańska A; Czartoryska B
    J Inherit Metab Dis; 1999 Apr; 22(2):203-4. PubMed ID: 10234625
    [No Abstract]   [Full Text] [Related]  

  • 39. [First Scandinavian Gaucher meeting. Treatment with enzyme substitution provides optimism for the future].
    Stolt CM
    Nord Med; 1992; 107(11):292-3, 298. PubMed ID: 1448346
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
    Sidransky E; Ginns EI; Westman JA; Ehmann WC
    Am J Hematol; 1994 Nov; 47(3):247-9. PubMed ID: 7942798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.